Stock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains

Stock Track2025-10-09

PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5% following its initial public offering (IPO), the stock took an unexpected turn, plummeting 6.25% by the end of the trading session.

The company had priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million. PomDoctor's shares began trading under the ticker symbol "POM" with high hopes, as the company aims to expand its presence in China's growing online healthcare market.

Despite the initial enthusiasm, PomDoctor's stock performance took a sharp downturn during intraday trading. While there was no specific negative news about the company, the sudden drop could be attributed to several factors common in IPO situations. These may include profit-taking by early investors, concerns about the company's valuation, or broader market volatility affecting newly listed stocks. It's also possible that investors are taking a cautious approach to the Chinese tech sector amid ongoing regulatory uncertainties.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1125137890?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 03:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125137890","market":"sg","top_or_hot":-1,"title":"Stock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains","media":"Stock Track","content":"<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5% following its initial public offering (IPO), the stock took an unexpected turn, plummeting 6.25% by the end of the trading session.</p>\n\n<p>The company had priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million. PomDoctor's shares began trading under the ticker symbol \"POM\" with high hopes, as the company aims to expand its presence in China's growing online healthcare market.</p>\n\n<p>Despite the initial enthusiasm, PomDoctor's stock performance took a sharp downturn during intraday trading. While there was no specific negative news about the company, the sudden drop could be attributed to several factors common in IPO situations. These may include profit-taking by early investors, concerns about the company's valuation, or broader market volatility affecting newly listed stocks. It's also possible that investors are taking a cautious approach to the Chinese tech sector amid ongoing regulatory uncertainties.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-09 03:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5% following its initial public offering (IPO), the stock took an unexpected turn, plummeting 6.25% by the end of the trading session.</p>\n\n<p>The company had priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million. PomDoctor's shares began trading under the ticker symbol \"POM\" with high hopes, as the company aims to expand its presence in China's growing online healthcare market.</p>\n\n<p>Despite the initial enthusiasm, PomDoctor's stock performance took a sharp downturn during intraday trading. While there was no specific negative news about the company, the sudden drop could be attributed to several factors common in IPO situations. These may include profit-taking by early investors, concerns about the company's valuation, or broader market volatility affecting newly listed stocks. It's also possible that investors are taking a cautious approach to the Chinese tech sector amid ongoing regulatory uncertainties.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"POM","symbol_name":"石榴云医","start_time":0,"source_url":"","article_id":"1125137890","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125137890","pubTimestamp":1759953143,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5%...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"POM":"石榴云医"},"translate_title":"个股追踪|PomDoctor IPO日大跌6.25%尽管初期上涨","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"POM":1},"content_text":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5% following its initial public offering (IPO), the stock took an unexpected turn, plummeting 6.25% by the end of the trading session.\nThe company had priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million. PomDoctor's shares began trading under the ticker symbol \"POM\" with high hopes, as the company aims to expand its presence in China's growing online healthcare market.\nDespite the initial enthusiasm, PomDoctor's stock performance took a sharp downturn during intraday trading. While there was no specific negative news about the company, the sudden drop could be attributed to several factors common in IPO situations. These may include profit-taking by early investors, concerns about the company's valuation, or broader market volatility affecting newly listed stocks. It's also possible that investors are taking a cautious approach to the Chinese tech sector amid ongoing regulatory uncertainties.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125137890","isCrawlerRequest":true}